Glucagon-Like Peptide 1 Attenuates Lipotoxicity-Induced Islet Dysfunction in ApoE–/– Mice
Fuqiang Liu,1– 4 Lei Gong,1– 4 Weidong Qin,5 Chen Cui,1– 4 Li Chen,1– 4 Mingxiang Zhang5 1Department of Endocrinology, Qilu Hospital, Shandong University, Jinan 250012, People’s Republic of China; 2Institute of Endocrine and Metabolic Diseases, Shand...
Enregistré dans:
Auteurs principaux: | Liu F, Gong L, Qin W, Cui C, Chen L, Zhang M |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/97a0af2aee414a74b630642ba6e12c23 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review
par: Teshome G, et autres
Publié: (2020) -
Islet Transplantation Imaging in vivo
par: Zheng L, et autres
Publié: (2020) -
Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review
par: Knop FK, et autres
Publié: (2010) -
Identification of key gene pathways and coexpression networks of islets in human type 2 diabetes
par: Li L, et autres
Publié: (2018) -
Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential
par: Bastin M, et autres
Publié: (2019)